Form 4 for AMPH Amphastar Pharmaceuticals, Inc.
Accepted 2024-08-02 00:00:00 ET · period of report 2024-07-31 · accession 0001415889-24-020626 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-08-02 | 2024-07-31 | AMPH | PETERS WILLIAM J | CFO, EVP, Treas, Dir | S - Sale+OE | $44.23 | -10.3K | 94.1K | -10% | -$454.8K |
| D | 2024-08-02 | 2024-07-31 | AMPH | PETERS WILLIAM J | CFO, EVP, Treas, Dir | M - OptEx | $20.23 | +10.3K | 104.4K | +11% | +$208.0K |
| D | 2024-08-02 | 2024-07-31 | AMPH | PETERS WILLIAM J | CFO, EVP, Treas, Dir | M - OptEx | $0.00 | -10.3K | 4,943 | -68% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-31 | S | D | 10,282 | $44.23 | 94,103 | D | — | — | |
| 2 | Common | Common Stock | 2024-07-31 | M | A | 10,282 | $20.23 | 104,385 | D | — | — | |
| 3 | Derivative | Employee Stock Option (right to buy) | 2024-07-31 | M | D | 10,282 | $0.00 | 4,943 | D | $20.23 · — to 2029-03-15 | 10,282 Common Stock | (F2) Shares subject to the option are fully vested and immediately exercisable. |